Envestnet Asset Management’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $376K | Sell |
4,275
-722
| -14% | -$63.5K | ﹤0.01% | 3903 |
|
2025
Q1 | $455K | Sell |
4,997
-781
| -14% | -$71.2K | ﹤0.01% | 3685 |
|
2024
Q4 | $499K | Sell |
5,778
-1,724
| -23% | -$149K | ﹤0.01% | 3582 |
|
2024
Q3 | $713K | Buy |
7,502
+336
| +5% | +$31.9K | ﹤0.01% | 3315 |
|
2024
Q2 | $656K | Buy |
7,166
+1,671
| +30% | +$153K | ﹤0.01% | 3299 |
|
2024
Q1 | $498K | Sell |
5,495
-1,378
| -20% | -$125K | ﹤0.01% | 3435 |
|
2023
Q4 | $559K | Buy |
6,873
+1,011
| +17% | +$82.3K | ﹤0.01% | 3269 |
|
2023
Q3 | $468K | Buy |
5,862
+856
| +17% | +$68.4K | ﹤0.01% | 3297 |
|
2023
Q2 | $394K | Buy |
5,006
+239
| +5% | +$18.8K | ﹤0.01% | 3345 |
|
2023
Q1 | $370K | Sell |
4,767
-63
| -1% | -$4.89K | ﹤0.01% | 3339 |
|
2022
Q4 | $375K | Buy |
4,830
+791
| +20% | +$61.5K | ﹤0.01% | 3274 |
|
2022
Q3 | $272K | Buy |
+4,039
| New | +$272K | ﹤0.01% | 3412 |
|
2015
Q3 | – | Sell |
-105,604
| Closed | -$7.47M | – | 3064 |
|
2015
Q2 | $7.47M | Buy |
105,604
+29,127
| +38% | +$2.06M | 0.04% | 466 |
|
2015
Q1 | $5.37M | Buy |
76,477
+22,097
| +41% | +$1.55M | 0.03% | 538 |
|
2014
Q4 | $3.5M | Sell |
54,380
-17,423
| -24% | -$1.12M | 0.04% | 280 |
|
2014
Q3 | $4.57M | Buy |
71,803
+47,749
| +199% | +$3.04M | 0.05% | 256 |
|
2014
Q2 | $1.49M | Buy |
+24,054
| New | +$1.49M | 0.02% | 435 |
|